Aesyra has developed an innovative technology system addressing sleep bruxism, a prevalent sleep disorder often associated with sleep apnea, impacting nearly a billion individuals globally. Combining a distinctive oral appliance device with proprietary sensors, Aesyra’s AesyBite™ has demonstrated a remarkable 70% reduction in bruxism activity, driven by innovative technologies and algorithms grounded in years of sleep research data. They have just closed today a financial round of $3M. “This significant investment marks a pivotal moment for Aesyra,” said Marco Letizia, founder and CEO of Aesyra. “We are thrilled to partner with Supermoon Capital and Creadd Ventures, who share our vision of driving meaningful change within the sleep industry. With their support, we are well-positioned to accelerate the deployment of our groundbreaking solutions, ultimately improving patient outcomes and advancing healthcare practices.”
